Emergency Contraception in Spain

July 2013 | 26 pages | ID: E3D218A3D2AEN
Euromonitor International Ltd

Abstracts

According to the latest report published by the Spanish contraception society, SEC, only 14% of Spanish females have used emergency contraception pills in Spain since the government allowed for this product to be bought without a prescription in 2009.

Euromonitor International's Emergency Contraception in Spain report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Emergency Contraception market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

Headlines
Trends
Competitive Landscape
Prospects
Category Data
  Table 1 Sales of Emergency Contraception: Value 2009-2012
  Table 2 Sales of Emergency Contraception: % Value Growth 2009-2012
  Table 3 Emergency Contraception Company Shares by Value 2008-2012
  Table 4 Emergency Contraception Brand Shares by Value 2009-2012
  Table 5 Forecast Sales of Emergency Contraception: Value 2012-2017
  Table 6 Forecast Sales of Emergency Contraception: % Value Growth 2012-2017
Bayer Hispania SA in Consumer Health (spain)
Strategic Direction
Key Facts
Summary 1 Bayer Hispania SA: Key Facts
Company Background
Production
Summary 2 Bayer Hispania SA: Production Statistics 2012
Competitive Positioning
Summary 3 Bayer Hispania SA: Competitive Position 2012
Executive Summary
No Light at the End of the Tunnel
Not Enough Money To Finance Everything
No Changes in the Competitive Environment
Grocery Retailers Benefit From Consumer Demand for Value for Money
Fears Over the Financial Rescue of Spain
Key Trends and Developments
the Spanish Economy Struggles
New Times Require New Laws
Demographics
A Country of Incongruencies
Climate Change Affects Sales
Market Indicators
  Table 7 Consumer Expenditure on Health Goods and Medical Services 2007-2012
  Table 8 Life Expectancy at Birth 2007-2012
Market Data
  Table 9 Sales of Consumer Health by Category: Value 2007-2012
  Table 10 Sales of Consumer Health by Category: % Value Growth 2007-2012
  Table 11 Consumer Health Company Shares 2008-2012
  Table 12 Consumer Health Brand Shares 2009-2012
  Table 13 Penetration of Private Label by Category 2007-2012
  Table 14 Sales of Consumer Health by Distribution Format: % Analysis 2007-2012
  Table 15 Sales of Consumer Health by Category and Distribution Format: % Analysis 2012
  Table 16 Forecast Sales of Consumer Health by Category: Value 2012-2017
  Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2012-2017
Appendix
OTC Registration and Classification
Consumer Health Registration and Classification
Advertising
Packaging and Labelling
Distribution
De-listing Or De-reimbursement
Vitamins and Dietary Supplements Registration and Classification
Retail Distribution
Alternative Therapy
Homoeopathic Medicines
Self-medication/self-care and Preventative Medicine
Switches
Summary 4 OTC: Switches 2010-2012
Definitions
Sources
Summary 5 Research Sources